Table 4.
Pretreatment, treatment, and outcome
| Variables | Moderate (n = 33) | Severe (n = 37) | p |
|---|---|---|---|
| Pretreatment | 10 (30.3) | 18 (48.6) | 0.118 |
| Antihistamine | 10 | 18 | |
| Hydrocortisone | 10 | 18 | |
| Treatment | |||
| H1 blocker | 33 (100.0) | 34 (91.9) | 0.242 |
| H2 blocker | 23 (69.7) | 23 (62.2) | 0.507 |
| β2 agonist nebulizer | 2 (6.1) | 2 (5.4) | 1.000 |
| Steroid | 25 (75.8) | 32 (86.5) | 0.249 |
| Hydrocortisone | 16 | 22 | |
| Methylprednisolone | 14 | 18 | |
| Dexamethasone | 0 | 0 | |
| Epinephrine | 11 (33.3) | 37 (100.0) | <0.001 |
| Intramuscular | 5 | 28 | |
| Subcutaneous | 3 | 3 | |
| Intravenous | 3 | 6 | |
| Disposition | 0.004 | ||
| Discharge | 26 (78.8) | 19 (51.4) | |
| Admission | 4 (12.1) | 17 (45.9) | |
| AMA discharge | 3 (9.1) | 1 (2.7) | |
| Death | 0 | 0 | |
AMA against medical advice, β 2 beta receptor 2, H 1 histamine receptor 1, H 2 histamine receptor 2